LOS ANGELES — A breast cancer patient has filed a claim against Sanofi S.A., Aventis Pharma S.A. and Sanofi-Aventis U.S. LLC after she allegedly suffered disfiguring permanent alopecia she contributes to medication prescribed by her oncologist.
Danah Anderson filed a complaint on Aug. 12 in U.S. District Court for the Central District of California against the defendants, alleging that they failed to inform consumers regarding the potential negative effects of Taxotere. The complaint cites alleged breach of implied warranty, failure to warn, fraud, negligence and product liability.
According to the complaint, the plaintiff alleges that, in September 2002, she was diagnosed with breast cancer and was prescribed Taxotere that resulted in permanent alopecia. The plaintiff holds Sanofi S.A., Aventis Pharma S.A., and Sanofi-Aventis U.S. LLC responsible because the defendants allegedly knew the negative effects caused by Taxotere but chose not to inform consumers regarding these effects.
The plaintiff requests a trial by jury and seeks special damages, treble damages, expert witness fees, all legal fees and interest, and any other relief as this court deems just. She is represented by Karen Barth Menzies of Gibbs Law Group LLP in El Segundo, Eric H. Gibbs and Amy M. Zeman of Gibbs Law Group LLP in Oakland and Norman E. Siegel of Stueve Siegel Hanson LLP in Kansas City, Missouri.
U.S. District Court for the Central District of California case number 2:16-cv-06046